CDSCO panel approves Oxford COVID-19 vaccine for emergency use
Team Udayavani, Jan 1, 2021, 5:47 PM IST
New Delhi: An expert panel on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has approved the emergency use authorisation for the Oxford COVID-19 vaccine Covishield, being manufactured by Serum Institute of India.
The Pune-based Serum Institute of India (SII), the world’s largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Wednesday had approved the COVID-19 vaccine developed by scientists at Oxford University and produced by AstraZeneca for human use.
The Subject Expert Committee (SEC) on COVID-19 of the CDSCO, which had earlier sought additional safety and immunogenicity data from SII, deliberated on its application seeking emergency use authorisation (EUA) for the shots on Wednesday, and met again on Friday to review the matter.
More details to be added
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Film of ‘do shehzade’ already rejected by people: Modi takes dig at Rahul, Akhilesh
Kejriwal accuses ED of being “petty”, “politicising” his food before court
Why crime rate against Dalits increasing in MP: Cong jabs PM Modi
Indian embassy urges caution for non-essential travel to UAE amid historic flooding
PM Modi accuses previous governments of deceiving SC, ST, OBCs in the guise of social justice at Amroha rally
MUST WATCH
Latest Additions
Film of ‘do shehzade’ already rejected by people: Modi takes dig at Rahul, Akhilesh
RCB helps restore three Bengaluru lakes; chips in to solve water crisis
Elderly tourist from Bengaluru goes missing in Goa
Kejriwal accuses ED of being “petty”, “politicising” his food before court
Bengaluru’s Shift to Smarter Spending: Pre-Owned Car Sales Jump 87 percent